The Primary
Care Companionfor CNS Disorders

Depression (MDD)

Article October 16, 2006

Commentary: Use of Treatment Algorithms for Depression

Madhukar H. Trivedi, M.D. ; Maurizio Fava, M.D. ; Lauren B. Marangell, M.D. ; David N. Osser, M.D. ; Richard C. Shelton, M.D.

Prim Care Companion J Clin Psychiatry 2006;8(5):291-298

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

View Related Activity

Go to Activity

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 27 • 2025 • Number 1

Read the Current Issue

Case Report

Thyrotoxic Psychosis in Graves’ Disease

Rounds in the General Hospital

Psychosis-Related PTSD

Case Report

Factitious Disorder in the Context of Abuse in an Adolescent

Rounds in the General Hospital

Wishing That Your Patient Would Die: Reasons and Reactions

Case Report

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Case Report

Low-Dose Clozapine in Schizophrenia With Aggression

View current Issue

Article

Brain Zaps

December 20, 2018

Brain zaps are a poorly understood symptom of antidepressant discontinuation, which require further study for both better prevention and treatment. This article describes the characteristics of brain zaps and...

Alexander Papp , Julie A. Onton

Article

ECT in Obsessive-Compulsive-Related Disorders

October 18, 2018

Obsessive-compulsive-related disorders include conditions such as body dysmorphic disorder and skin-picking disorder, as well as tic disorders and self-injurious behaviors. Could electroconvulsive therapy be an effective treatment option? Read...

Samara dos Santos-Ribeiro , Juliana B. de Salles Andrade , Julliana N. Quintas , et al

Article

Glabellar Botulinum for Depression

October 4, 2018

Glabellar injection of botulinum toxin A (BTA) provides a novel and interesting strategy to address shortcomings in the treatment of depression. This study examines the primary clinical trials conducted...

Toren P. Stearns , Mujeeb U. Shad , Gabriela C. Guzman

Commentary: Use of Treatment Algorithms for Depression

Read the Current Issue

Thyrotoxic Psychosis in Graves’ Disease

Psychosis-Related PTSD

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

ELSEWHERE:

FOLLOW US:

Commentary: Use of Treatment Algorithms for Depression

Read the Current Issue

Thyrotoxic Psychosis in Graves’ Disease

Psychosis-Related PTSD

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

Related Articles

Brain Zaps

ECT in Obsessive-Compulsive-Related Disorders

Glabellar Botulinum for Depression

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles